Navigation Links
FierceBiotech Names NanoBio Corporation as One of the 'Fierce 15' Biotech Companies of 2008

ANN ARBOR, Mich., June 24 /PRNewswire/ -- NanoBio Corp. announced today that it has been named to the annual FierceBiotech "Fierce 15" list, designating NanoBio as one of the top biotechnology companies of 2008.

The editors of FierceBiotech evaluated hundreds of privately held firms based on company vision, revenue potential, quality of deals, strength of technology, partnerships and competitive market position. NanoBio was determined to be one of the "fiercest," proven by its creativity and innovations in the industry, according to the editors of FierceBiotech.

NanoBio, a spin-out from the University of Michigan, has developed a rich pipeline of anti-infective lotions and vaccines to combat a diverse range of bacteria, viruses and fungi, from MRSA to hepatitis B. Their platform uses a high-energy nanoemulsion to directly target and physically disrupt the outer membranes of pathogens, without toxicity or systemic absorption.

John Carroll, editor of FierceBiotech, said, "This University of Michigan spin-out has advanced its technology on topical agents into phase II trials and promises to make big gains in the way that vaccines are developed and manufactured. The data look promising, a phase III looms, partnerships beckon, and then there's the lure of a possible IPO in the not-too-distant future. For a nano-bio company, NanoBio is well ahead of the pack."

NanoBio's lead treatments are topical lotions for cold sores and nail fungus. Recent data from phase 2 trials demonstrate that their topical treatment for cold sores achieves the efficacy of leading systemic treatments with none of their safety, toxicity or drug interaction concerns. In addition, animal studies indicate that NanoBio's vaccines quickly trigger robust immunity -- without adverse effects -- against a wide array of viruses and bacteria, including influenza, hepatitis B, RSV and anthrax.

"It is really gratifying to have our work recognized by a major voice in the field of biotechnology, especially in an area where so many innovative companies are seeking to improve the health and well being of the global community," said James R. Baker Jr., M.D., founder and chairman of NanoBio Corp. "Being selected as a member of the Fierce 15 is an honor that highlights NanoBio's potential to make a significant impact in the biotech market."

FierceBiotech is an internationally recognized daily newsletter reaching more than 65,000 biotechnology and pharmaceutical industry professionals. The newsletter provides subscribers with a quick, authoritative briefing on the day's top stories, with a special focus on drug discovery and clinical trials.

The Fierce 15 celebrates the spirit of being fierce -- championing innovation and creativity, even in the face of intense competition. The complete list of Fierce 15 companies is available in today's issue of FierceBiotech and on the FierceBiotech Web site at .

About NanoBio

NanoBio(R) Corporation is a privately held biopharmaceutical company focused on developing and commercializing anti-infective products and mucosal vaccines derived from its patented NanoStat(TM) technology platform. The company's lead product candidates are treatments for herpes labialis (cold sores), onychomycosis (nail fungus), MRSA and mucosal vaccines for influenza and hepatitis B. The company's headquarters and laboratory facilities are located in Ann Arbor, Mich.

SOURCE NanoBio Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. KGI Names Kerry Howell Vice President for Advancement
2. Vical Names Andrew de Guttadauro Vice President, Corporate Development
3. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
4. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
5. CryoLife Names Philip Theodore as Vice President, General Counsel
6. Genstar Names Michael Hurt to Its Strategic Advisory Board
7. PPD Names Daniel Darazsdi as Chief Financial Officer
8. Society of Laproendoscopic Surgeons Names Starion Instruments 2007 Innovator of the Year
9. Cadence Pharmaceuticals Names Malvina Laudicina Vice President of Regulatory Affairs and Quality Assurance
10. Mpex Pharmaceuticals Names Dr. Jeffery Loutit as Chief Medical Officer
11. Osprey Pharmaceuticals Names Jack M. Anthony as CEO
Post Your Comments:
(Date:11/26/2015)... 26, 2015 ... Accutest Research Laboratories, a leading independent ... (CRO), has formed a strategic partnership ... Temple Health for joint work on ... ) , --> ...
(Date:11/25/2015)... , November 25, 2015 ... cat and human plaque and pave the way for more ... problems in cats     --> ... most commonly diagnosed health problems in cats, yet relatively little ... now. Two collaborative studies have been conducted by researchers from ...
(Date:11/25/2015)... Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) ... chat discussion at the Piper Jaffray 27th Annual Healthcare ... discussion is scheduled for Wednesday, December 2, at 8:00 ... replay will be available for 14 days after the ... NormartVP, Corporate Communications and Business Development , BrewLife(858) 875-8629 ...
(Date:11/24/2015)... , Nov. 24, 2015 Cepheid (NASDAQ: ... speaking at the following conference, and invited investors to ... NY      Tuesday, December 1, 2015 at 11.00 ... NY      Tuesday, December 1, 2015 at 11.00 ... Conference, New York, NY      Tuesday, ...
Breaking Biology Technology:
(Date:11/2/2015)...  SRI International has been awarded a contract of ... to the National Cancer Institute (NCI) PREVENT Cancer Program ... modern testing and support facilities, and analytical instrumentation to ... studies to evaluate potential cancer prevention drugs. ... Drug Development Program is an NCI-supported pipeline to bring ...
(Date:10/29/2015)... ANN ARBOR, Mich. , Oct. 29, 2015 ... with Eurofins Genomics for U.S. distribution of its ... DNA-seq kit and Rubicon,s new ThruPLEX Plasma-seq ... DNA to enable the preparation of NGS libraries ... in plasma for diagnostic and prognostic applications in ...
(Date:10/27/2015)... 2015 In the present market scenario, security ... various industry verticals such as banking, healthcare, defense, electronic ... demand for secure & simplified access control and growing ... hacking of bank accounts, misuse of users, , and ... PC,s, laptops, and smartphones are expected to provide potential ...
Breaking Biology News(10 mins):